1 Min Read
Oct 12 (Reuters) - SynCore Biotechnology :
* Says it got patent for treatment of triple receptor negative breast cancer from European Patent Office
Source text in Chinese: goo.gl/7XqKL6
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.